Royal DSM To Acquire Majority Shareholding In China-based ICD

The Netherlands-based life and material sciences company Royal DSM NV has entered into an agreement
to become the majority shareholder in China-based Shandong ICD High Performance Fibre Co. Ltd.
(ICD), a manufacturer of ultra-high-molecular-weight polyethylene (UHMWPE) fiber. According to DSM,
ICD is a strong player in the high-performance fiber market in China, and the acquisition will
strengthen DSM’s position in that market, bringing complementary technologies and manufacturing
resources.

“China is a key market for DSM and we will continue to grow our long term commitment to it,”
said Nico Gerardu, DSM Managing Board member responsible for DSM’s Performance Materials cluster.
“We have invested significant time and effort to identify the right partner to ally with for this
acquisition and we are extremely excited about the prospect of bringing ICD into the DSM
portfolio.”

“This is an exciting development for everyone at ICD and I believe it will help to secure our
future growth and success in the Chinese UHMWPE fiber market,” said Ren Yi, general manager, ICD.

March 16, 2011

SHARE